Stem cells in the spleen: Therapeutic potential for Sjogren's syndrome, type I diabetes, and other disorders

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 10, 2010, Pages 1576-1579

  Faustman, Denise L ^a   Davis, Miriam ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Regeneration; Sjogrens; Spleen; Stem cells; Type 1 diabetes

Indexed keywords

DNA BINDING PROTEIN; PROTEIN HOX11; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CELL DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MIGRATION; CELL REGENERATION; EPITHELIUM CELL; HEART MUSCLE CELL; HUMAN; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPOTENT STEM CELL; NERVE CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SHORT SURVEY; SJOEGREN SYNDROME; SPLEEN CELL;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; DIABETES MELLITUS, TYPE 1; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; PROTO-ONCOGENE PROTEINS; SJOGREN'S SYNDROME; SPLEEN; STEM CELL NICHE; STEM CELL TRANSPLANTATION;

ANIMALIA; IPS;

EID: 77956188833     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.06.012     Document Type: Short Survey

References (31)

1. Anderson D.J. Stem cells and pattern formation in the nervous system: the possible versus the actual. Neuron 2001, 30:19-35.
2. Chadburn A. The spleen: anatomy and anatomical function. Semin Hematol 2000, 37:13-21.
3. Dear T.N., Colledge W.H., Carlton M.B., Lavenir I., Larson T., Smith A.J., et al. The Hox11 gene is essential for cell survival during spleen development. Development 1995, 121:2909-2915.
4. Dieguez-Acuna F., Kodama S., Okubo Y., Paz A.C., Gygi S.P., Faustman D.L. Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen. Int J Biochem Cell Biol 2009.
5. Dieguez-Acuna F.J., Gygi S.P., Davis M., Faustman D.L. Splenectomy: a new treatment option for ALL tumors expressing Hox-11 and a means to test the stem cell hypothesis of cancer in humans. Leukemia 2007, 21:2192-2194.
6. Hayashi T., Faustman D. NOD mice are defective in proteasome production and activation of NF- kappaB. Mol Cell Biol 1999, 19:8646-8659.
7. Hayashi T., Faustman D. Essential role of HLA-encoded proteasome subunits in NF-kB activation and prevention of TNF-a induced apoptosis. J Biol Chem 2000, 275:5238-5247.
8. Khaldoyanidi S., Sikora L., Broide D.H., Rothenberg M.E., Sriramarao P. Constitutive overexpression of IL-5 induces extramedullary hematopoiesis in the spleen. Blood 2003, 101:863-868.
9. Kodama S., Davis M., Faustman D.L. Diabetes and stem cell researchers turn to the lowly spleen. Sci Aging Knowledge Environ 2005, pe2.
10. Kodama S., Davis M., Faustman D.L. Regenerative medicine: a radical reappraisal of the spleen. Trends Mol Med 2005, 11:271-276.
11. Kodama S., Davis M., Faustman D.L. The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis. Cell Mol Life Sci 2005, 62:1850-1862.
12. Kodama S., Kuhtreiber W., Fujimura S., Dale E.A., Faustman D.L. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003, 302:1223-1227.
13. Lonyai A., Kodama S., Burger D., Davis M., Faustman D.L. The promise of Hox11+ stem cells of the spleen for treating autoimmune diseases. Horm Metab Res 2008, 40:137-146.
14. Lonyai A., Kodama S., Burger D., Faustman D.L. Fetal Hox11 expression patterns predict defective target organs: a novel link between developmental biology and autoimmunity. Immunol Cell Biol 2008, 86:301-309.
15. Macias M.P., Fitzpatrick L.A., Brenneise I., McGarry M.P., Lee J.J., Lee N.A. Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice. J Clin Invest 2001, 107:949-959.
16. Madec A.M., Mallone R., Afonso G., et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 2009, 52:1391-1399.
17. Nishio J., Gaglia J.L., Turvey S.E., Campbell C., Benoist C., Mathis D. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 2006, 311:1775-1778.
18. Park S., Hong S.M., Ahn I.S. Can splenocytes enhance pancreatic beta-cell function and mass in 90% pancreatectomized rats fed a high fat diet?. Life Sci 2009, 84:358-363.
19. Raju K., Tang S., Dube I.D., Kamel-Reid S., Bryce D.M., Breitman M.L. Characterization and developmental expression of Tlx-1, the murine homolog of HOX11. Mech Dev 1993, 44:51-64.
20. Roberts C.W., Shutter J.R., Korsmeyer S.J. Hox11 controls the genesis of the spleen. Nature 1994, 368:747-749.
21. Roberts C.W., Sonder A.M., Lumsden A., Korsmeyer S.J. Developmental expression of Hox11 and specification of splenic cell fate. Am J Pathol 1995, 146:1089-1101.
22. Robertson S.A., Rowan-Hull A.M., Johnson P.R. The spleen-a potential source of new islets for transplantation?. J Pediatr Surg 2008, 43:274-278.
23. Ryu S., Kodama S., Ryu K., Schoenfeld D.A., Faustman D.L. Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J Clin Invest 2001, 108:63-72.
24. Suri A., Calderon B., Esparza T.J., Frederick K., Bittner P., Unanue E.R. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science 2006, 311:1778-1780.
25. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
26. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
27. Tan J.K., Periasamy P., O'Neill H.C. Delineation of precursors in murine spleen that develop in contact with splenic endotherlium to give novel dendritic-like cells. Blood 2010, 6:3678-3685.
28. Tran S., Kodama S., Mezey E.M. Treatment success and regenerative mechanisms influenced by age of NOD mice and target organ of autoimmune attack. 66th Session of American Diabetes Association 2006, A283. American Diabetes Association, Washington, DC, [Abstract #1202-P].
29. Tran S.D., Kodama S., Lodde B.M., Szalayova I., Key S., Khalili S., et al. Reversal of Sjogren's-like syndrome in non-obese diabetic mice. Ann Rheum Dis 2007, 66:812-814.
30. Yao H., Liu B., Wang X., Lan Y., Hou N., Yang X., et al. Identification of high proliferative potential precursors with hemangioblastic activity in the mouse aorta-gonad-mesonephros region. Stem Cells 2007, 25:1423-1430.
31. Yin D., Tao J., Lee D.D., Shen J., Hara M., Lopez J., et al. Recovery of islet beta-cell function in streptozotocin-induced diabetic mice: an indirect role for the spleen. Diabetes 2006, 55:3256-3263.